Trial
NCT07532408
Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Peking Union Medical College Hospital
Collaborators
—
Condition
Aplastic Anemia
Intervention
Romiplostim N01
Why stopped
The registration of this research plan was incorrect. A new registration has been done.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04